Qian Changgeng 4
4 · CURIS INC · Filed Feb 6, 2009
Insider Transaction Report
Form 4
CURIS INCCRIS
Qian Changgeng
VP, Research & Preclinical Dev
Transactions
- Award
Qualified stock option (right to buy)
2009-02-05+20,210→ 20,210 totalExercise: $1.07Exp: 2019-02-05→ Common stock (20,210 underlying) - Award
Non-qualified stock option (right to buy)
2009-02-05+159,790→ 159,790 totalExercise: $1.07Exp: 2019-02-05→ Common stock (159,790 underlying)
Footnotes (1)
- [F1]Options in the aggregate will vest 25% on the one-year anniversary grant date, or February 5, 2010. Remaining options will vest at 6.25% each successive three-month period, with non-qualified options vesting first. Options will be fully vested four years from the grant date.